Small bowel perforation secondary to metastatic non-small cell lung cancer. A rare entity with a dismal prognosis. 2012

Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
Second Department of Surgery, Army General Hospital, 19 Taxiarhon Str, 19014, Kapandriti, Athens, Greece. nikos_salemis@hotmail.comp

OBJECTIVE The incidence of gastrointestinal metastases from lung cancer is higher than previously thought as they have been reported in 2-14% of the cases in autopsy studies. However, clinically significant metastases are rare. Small bowel perforation secondary to metastatic non-small cell lung cancer is a very rare clinical entity. The aim of this study is to describe a case of ileal perforation in a patient with intestinal metastases of a non-small cell lung cancer, along with a review of the literature. METHODS A 57-year-old male with a history of non-small cell lung cancer was referred to our emergency department with signs and symptoms of acute surgical abdomen. A computed tomography scan demonstrated dilated small bowel loops, liver deposits, and signs of perforation of an intra-abdominal hollow viscus. RESULTS Emergency exploratory laparotomy revealed diffuse purulent peritonitis and a perforated ileal tumor. A segmental small bowel resection and primary anastomosis were performed. Histological and immunohistochemical findings were consistent with a metastatic non-small cell lung carcinoma. Additional evaluation revealed widespread metastatic disease. Unfortunately, despite adjuvant treatment, the patient died of progressive disease 2 months after surgery. CONCLUSIONS Small bowel perforation due to metastatic non-small cell lung cancer is a very rare clinical entity. The possibility of small bowel metastases should be kept in mind in patients with lung cancer presenting with an acute abdomen. Intestinal perforation occurs in advanced stages and is usually a sign of widespread disease. Aggressive surgery can provide effective palliation and may improve short-term survival. The prognosis is however dismal.

UI MeSH Term Description Entries
D007416 Intestinal Perforation Opening or penetration through the wall of the INTESTINES. Intestinal Perforations,Perforation, Intestinal,Perforations, Intestinal
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
January 1981, Annals of surgery,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
February 1988, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
December 2023, Cureus,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
July 1999, The Tohoku journal of experimental medicine,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
July 1977, Cancer,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
May 2020, Archivos de bronconeumologia,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
April 2007, Saudi medical journal,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
March 2003, The Mount Sinai journal of medicine, New York,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
December 2018, Molecular and clinical oncology,
Nikolaos S Salemis, and Efstathios Nikou, and Christos Liatsos, and Christos Gakis, and Grigorios Karagkiouzis, and Stavros Gourgiotis
February 2005, The American surgeon,
Copied contents to your clipboard!